Distribution of body fat and risk of coronary heart disease in men and women

Current Opinion in Cardiology

Volumn 23, Issue 6, 2008, Pages 591-598

  Canoy, Dexter ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Coronary disease; Fat distribution; Obesity; Waist circumference; Waist hip ratio

Indexed keywords

CHOLESTEROL;

BLOOD PRESSURE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIETARY INTAKE; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; BODY FAT DISTRIBUTION; BODY MASS INDEX; CORONARY ARTERY DISEASE; FEMALE; GREAT BRITAIN; HUMANS; MALE; OBESITY; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 55149120717     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328313133a     Document Type: Review

References (60)

1. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4:20-34.
2. Bjorntorp P. Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10:493-496.
3. Despres JP, Prud'homme D, Pouliot MC, et al. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54:471-477.
4. Man TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311:1401-1405.
5. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
7. National Institute for Health and Clinical Excellence. Obesity. Guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. http://www.nice.org.uk/guidance/CG43/?c=91500. Accessed on 5 June 2008.
8. Lemieux S, Prud'homme D, Bouchard C, et al. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993; 58:463-467.
9. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4:499-502.
10. Yang L, Kuper H, Weiderpass E. Anthropometric characteristics as predictors of coronary heart disease in women. J Intern Med 2008; 264:39-49.
11. Aekplakorn W, Pakpeankitwatana V, Lee CM, et al. Abdominal obesity and coronary heart disease in Thai men. Obesity (Silver Spring) 2007; 15:1036-1042.
12. Onat A, Uyarel H, Hergenc G, et al. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191:182-190.
13. Asia Pacific Cohort Studies Collaboration. Central obesity and risk of cardiovascular disease in the Asia Pacific Region. Asia Pac J Clin Nutr 2006; 15:287-292.
14. Li TY, Rana JS, Manson JE, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113:499-506.
15. Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007; 116:2933-2943. This population-based study described in more detail the nature of the association between fat distribution indices and coronary heart disease in men and women. The study has shown for the first time that hip circumference is independently and inversely related to coronary heart disease in both men and women.
16. Jensen MK, Chiuve SE, Rimm EB, et al. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation 2008; 117:3062-3069. This is a large population-based study that showed that leading a healthy lifestyle could not offset the impact of obesity on coronary disease.
17. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord 2001; 25:1047-1056.
18. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995; 141:1117-1127.
19. Wacholder S. When measurement errors correlate with truth: surprising etfects of nondifferential misclassification. Epidemiology 1995; 6:157-161.
20. Greenland S. The etfect of misclassification in the presence of covariates. Am J Epidemiol 1980; 112:564-569.
21. Rawlings JO, Pantula SG, Dickey DA. Applied regression analysis: a research tool. 2nd ed. New York: Springer-Verlag; 1998.
22. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280:1843-1848.
23. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999; 22:1808-1812.
24. Votruba SB, Jensen MD. Regional fat deposition as a factor in FFA metabolism. Annu Rev Nutr 2007; 27:149-163. This review on fatty acid metabolism highlighted findings using in-vivo studies and described sex differences in fatty acid storage and release.
25. Koutsari C, Dumesic DA, Patterson BW, et al. Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes 2008; 57:1186-1194. Using in-vivo protocol, this study investigated mechanisms that might explain the preterential lower body fat accumulation in women and showed that this propensity could increase with increasing body size.
26. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69-e171. This report provided an updated and detailed epidemiology and description of the burden of heart disease and stroke in the United States in 2007.
27. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-1649.
28. Thomas EL, Saeed N, Hajnal JV, et al. Magnetic resonance imaging of total body fat. J Appl Physiol 1998; 85:1778-1785.
29. Thorne A, Lonnqvist F, Apelman J, et al. A pilot study of long-term etfects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding, Int J Obes Relat Metab Disord 2002; 26:193-199.
30. Klein S, Fontana L, Young VL, et al. Absence of an etfect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350:2549-2557.
31. Canoy D, Luben R, Welch A, et al. Fat distribution, body mass index and blood pressure in 22 090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004; 22:2067-2074.
32. Canoy D, Wareham N, Luben R, et al. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis 2006; 189:420-427.
33. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite etfects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001; 74:315-321.
34. Snijder MB, Visser M, Dekker JM, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005; 48:301-308.
35. Yim JE, Heshka S, Albu JB, et al. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol 2008; 104:700-707. Using both DEXA and MRI techniques, this investigation confirmed the inverse association between femoro-gluteal subcutaneous (but not intra-muscular) fat and with adverse cardiovascular risk factors (after adjusting for total adiposity) in men and women of different ethnic origins.
36. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004; 89:463-478.
37. Homko CJ, Cheung P, Boden G. Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 2003; 52:487-491.
38. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005; 19:471-482.
39. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92:2191-2198.
40. Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56:1010-1013. This study is probably the first to assess IL-6 concentration directly in the portal circulation in humans and compared it with the IL-6 concentration in the brachial artery.
41. Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145:2273-2282.
42. Peverill RE, Teede HJ, Malan E, et al. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) 2007; 113:383-391. This study demonstrated for the first time that waist and hip circumference have separate and opposite associations with intravascular coagulation activation.
43. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28:1039-1049. The authors presented the case for the relevance of abdominal obesity in the development of metabolic syndrome and how these factors could be incorporated in assessing global cardiometabolic risk.
44. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002; 45:1201-1210.
45. Simha V, Garg A. Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol 2006; 17:162-169.
46. Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105:271-278.
47. Kim JY, van de WE, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117:2621-2637. This landmark study demonstrated that subcutaneous fat mass expansion in obese mice led to the normalization of metabolic parameters and that adinopectin may be involved in regulating this fat mass expansion.
48. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7:410-420. This investigation showed that it is probably not the location but an inherent characteristic of subcutaneous fat tissue that improves glucose metabolism.
49. Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997; 100:3149-3153.
50. Mori Y, Murakawa Y, Okada K, et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diab Care 1999; 22:908-912.
51. Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000; 26:13.
52. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 2004; 28:S12-S21.
53. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
54. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311:158-161.
55. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) 2007; 15: 1061-1067. This recent consensus statement highlighted the difficulty of using currently recommended waist circumference cut-points; using these cut-points is unlikely to provide additional relevant clinical information about the patient that could alter management or treatment.
56. Slentz CA, Duscha BD, Johnson JL, et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Arch Intern Med 2004; 164:31-39.
57. Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002; 87:2784-2791.
58. Canoy D, Wareham N, Luben R, et al. Cigarette smoking and fat distribution in 21 828 British men and women: a population-based study. Obes Res 2005; 13:1466-1475.
59. Kahn HS, Tatham LM, Heath CW Jr. Contrasting factors associated with abdominal and peripheral weight gain among adult women, Int J Obes Relat Metab Disord 1997; 21:903-911.
60. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35:83-92.